Specific human cholangiocarcinoma (CCA) subpopulations of cancer stem cells (CSCs) express DoubleCortin-Like Kinase 1 (DCLK1) and DCLK1 inhibition induces anti-cancer effects

被引：0
|
作者：
Nevi, L. [1 ]
Di Matteo, S. [1 ]
Carpino, G. [2 ]
Cardinale, V. [3 ]
Zizzari, I. [4 ]
Ambrosino, V. [1 ]
Costantini, D. [1 ]
Safarikia, S. [1 ]
Manzi, E. [5 ]
Derose, A. M. [6 ]
Melandro, F. [7 ]
Bragazzi, M. C. [3 ]
Grazi, G. [5 ]
Berloco, P. B. [7 ]
Giuliante, F. [6 ]
Gaudio, E. [8 ,9 ]
Alvaro, D. [1 ]
机构：
[1] Sapienza Univ Rome, Dept Med & Med Specialties, Rome, Italy
[2] Univ Rome Foro Italico, Div Hlth Sci, Dept Movement Human & Hlth Sci, Rome, Italy
[3] Sapienza Univ Rome, Dept Med Surg Sci & Biotechnol, Rome, Italy
[4] Sapienza Univ Rome, Dept Expt Med, Rome, Italy
[5] Regina Elena Inst Canc Res, Gastroenterol Unit, Rome, Italy
[6] Univ Cattolica Sacro Cuore, Sch Med, Surg Hepatobiliary Unit, Rome, Italy
[7] Sapienza Univ Rome, Dept Gen Surg & Organ Transplantat, Rome, Italy
[8] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, Rome, Italy
[9] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, Div Human Anat, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2018年 / 50卷 / 01期
关键词：
D O I：
10.1016/j.dld.2018.01.012
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC-08
引用
收藏
页码：5 / 6
页数：2
相关论文
共 50 条
  • [1] DOUBLECORTIN-LIKE KINASE 1 (DCLK1) IS A MARKER OF SPECIFIC SUBPOPULATIONS OF CANCER STEM CELLS (CSCS) IN HUMAN CHOLANGIOCARCINOMA (CCA) AND ITS INHIBITION EXERTS ANTI-CANCER EFFECTS
    Nevi, L.
    Di Matteo, S.
    Carpino, G.
    Cardinale, V.
    Ambrosino, V.
    Costantini, D.
    Safarikia, S.
    Manzi, E.
    De Rosa, A. M.
    Melandro, F.
    Bragazzi, M. C.
    Grazi, G.
    Berloco, P. B.
    Giuliante, F.
    Gaudio, E.
    Alvaro, D.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E86 - E87
  • [2] Targeting Doublecortin-like Kinase 1 (DCLK1) in Colon Cancer: An <it>In</it>-<it>silico</it> Approach
    Parsai, Janhvi
    Crockett, Cooper
    Kimball, Hunter
    Raval, Nipam
    FASEB JOURNAL, 2020, 34
  • [3] Enhanced Expression of Doublecortin-Like Kinase 1 (DCLK1) in the Background Mucosa of Colon Cancer
    Hirata, Yuki
    Sezaki, Takuhito
    Hagiwara, Teruki
    Edogawa, Shoko
    Okada, Toshihiko
    Inoue, Takuya
    Yano, Hideaki
    Gohda, Yoshimasa
    Suda, Ryuichiro
    Hirose, Yoshinobu
    Kawamura, Yutaka J.
    Higuchi, Kazuhide
    Dohi, Taeko
    Kawamura, Yuki I.
    GASTROENTEROLOGY, 2015, 148 (04) : S572 - S572
  • [4] ROLE OF DOUBLECORTIN-LIKE KINASE 1 (DCLK1) POSITIVE TUFT CELLS IN COLITIS-ASSOCIATED COLORECTAL CANCER
    Shin, Alice E.
    Fazio, Elena N.
    Zhang, Liyue
    Good, Hayley
    Sherman, Philip M.
    Wang, Timothy C.
    Asfaha, Samuel
    GASTROENTEROLOGY, 2018, 154 (06) : S23 - S23
  • [5] DoubleCortin/Like Kinase 1 (DCLK1) expression characterized specific cancer stem cell subpopulations of human cholangiocarcinoma primary cell cultures where its inhibition exerts anti-neoplastic effects
    Di Matteo, Sabina
    Nevi, Lorenzo
    Cardinale, Vincenzo
    Zizzari, Ilaria Grazia
    Ambrosino, Valeria
    Biancaniello, Francesca
    Costantini, Daniele
    Safarikia, Samira
    De Peppo, Valerio
    De Rose, Agostino Maria
    Melandro, Fabio
    Bragazzi, Mariaconsiglia
    Giuliante, Felice
    Berloco, Pasquale B.
    Grazzi, Gianluca
    Carpino, Guido
    Gaudio, Eugenio
    Alvaro, Domenico
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E360 - E361
  • [6] Pleiotropic effects of DCLK1 in cancer and cancer stem cells
    Chhetri, Dibyashree
    Vengadassalapathy, Srinivasan
    Venkadassalapathy, Santhosh
    Balachandran, Varadharaju
    Umapathy, Vidhya Rekha
    Veeraraghavan, Vishnu Priya
    Jayaraman, Selvaraj
    Patil, Shankargouda
    Iyaswamy, Ashok
    Palaniyandi, Kanagaraj
    Gnanasampanthapandian, Dhanavathy
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [7] Doublecortin-like Kinase 1 (DCLK1) correlates with the cell proliferation in malignant pleural mesothelioma
    Miura, Akihiro
    Yamamoto, Hiromasa
    Tao, Hiroyuki
    Suzawa, Ken
    Miyauchi, Syunsaku
    Araki, Kota
    Takahashi, Yuta
    Kurihara, Eisuke
    Ogoshi, Yusuke
    Shien, Kazuhiko
    Soh, Junichi
    Okabe, Kazunori
    Tomida, Shuta
    Sakaguchi, Masakiyo
    Toyooka, Shinichi
    CANCER RESEARCH, 2019, 79 (13)
  • [8] Doublecortin-like kinase 1 (DCLK1) is novel Notch pathway signaling regulator in HNSCC
    Broner, Esther Channah
    Subbannayya, Tejaswini
    Zhavoronkov, Alex
    Korzinkin, Mike
    Artemov, Artem
    Ozerov, Ivan
    Sloma, Ido
    Sidransky, David
    Chatterjee, Aditi
    Izumchenko, Evgeny
    CANCER RESEARCH, 2019, 79 (13)
  • [9] Expression of a Novel Stem Cell Marker Doublecortin-Like Kinase 1 (DCLK1) in Human Colorectal Polyps and Adenocarcinomas
    Shakir, Faiz
    May, Randal
    Sureban, Sripathi M.
    Lightfoot, Stanley
    Madhoun, Mohammad F.
    Houchen, Courtney W.
    GASTROENTEROLOGY, 2013, 144 (05) : S876 - S877
  • [10] First-in-class Doublecortin-like kinase 1 (DCLK1) inhibitor for targeting cancer stem cell in hepatocellular carcinoma.
    Yoon, Daseul
    Jung, Seung Hee
    Jang, Ju Young
    Ahn, Ji-Young
    Jo, Seung Jin
    Ko, Donghyun
    Kim, Dong-kyu
    Yu, Su Jong
    CANCER RESEARCH, 2022, 82 (12)
12345